Results 51 to 60 of about 299,239 (347)
FAVIPIRAVIR AS A POTENTIAL DRUG IN THE TREATMENT OF COVID-19
International Journal of Research -GRANTHAALAYAH, 2020 Favipiravir is a drug developed for use against influenza and has been used successfully in other infectious conditions. After being internalized in the cell, the substance is phosphoribosylated acting on the RNA polymerase, and thus inhibiting replication and RNA viruses.
Dany Geraldo Kramer +6 more
openaire +4 more sources
Identifying side effects of commonly used drugs in the treatment of Covid 19
Scientific Reports, 2020 To increase the success in Covid 19 treatment, many drug suggestions are presented, and some clinical studies are shared in the literature. There have been some attempts to use some of these drugs in combination.
İrfan Aygün, Mehmet Kaya, Reda Alhajj
doaj +1 more source
Медицинский совет, 2021 Medicinal liver damage is an important problem not only in the framework of hepatology and gastroenterology, but also for internal medicine in general, which is due to the difficulties of correct and timely diagnosis of this pathology. In the first
D. I. Trukhan, E. L. Davydov
doaj +1 more source
A brief overview of current drug repurposing approaches for COVID-19 management [PDF]
, 2020 This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares +1 more
core +2 more sources
Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
Antimicrobial Agents and Chemotherapy, 2021 Finding antivirals to reduce coronavirus disease 2019 (COVID-19) morbidity and mortality has been challenging. Large randomized clinical trials that aimed to test four repurposed drugs, hydroxychloroquine, lopinavir-ritonavir, interferon beta 1a, and remdesivir, have shown that these compounds lack an impact on the COVID-19 course.
openaire +4 more sources
Drug Candidates for Covid-19 Treatment in Brazil [PDF]
Clinical Cardiology and Cardiovascular Interventions, 2021 Background: COVID-19 has emerged worldwide in less than 6 months, leaving millions of deaths behind. While scientist search for new drugs, an old arsenal has been proposed as a form of treatment. Objective: This article was designed as a literature review, scrutinizing antiparasitic chloroquine, ivermectin, nitazoxanide; and also glucocorticoids, as ...
openaire +1 more source
Frontiers in Pharmacology, 2020 Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and
Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
doaj +1 more source
Journal of Rawalpindi Medical College, 2020 Background: COVID-19 shows variability depending on ethnicity and environmental factors therefore one type of drug may not be effective in all the populations. Personalized medicine refers to tailoring the treatment in accordance with individual patients.
Manzoor Khan +5 more
doaj +1 more source
Frontiers in Endocrinology, 2022 Coronavirus disease 2019 (COVID-19) is a serious epidemic, characterized by potential mutation and can bring about poor vaccine efficiency. It is evidenced that patients with malignancies, including prostate cancer (PC), may be highly vulnerable to the ...
Yu Ye +6 more
doaj +1 more source
A Quantitative Study on the Impact of COVID-19 on Drug Treatment Courts [PDF]
, 2023 The purpose of this research study was to investigate how the COVID-19 pandemic impacted drug treatment courts (DTCs) in Pennsylvania. DTCs were created as an alternative to the traditional court system by allowing those convicted of a drug offense to ...
Kingsbury, Derek J
core +1 more source